Target Price | $218.41 |
Price | $232.88 |
Deviation | 6.21% |
Number of Estimates | 17 |
17 Analysts have issued a price target IBM 2025 . The average IBM target price is $218.41. This is 6.21% lower than the current stock price. The highest price target is $250.00 7.35% , the lowest is $145.00 37.74% . | |
A rating was issued by 22 analysts: 10 Analysts recommend IBM to buy, 7 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2025 of 6.21% . Most analysts recommend the IBM stock at Purchase. |
15 Analysts have issued a sales forecast IBM 2024 . The average IBM sales estimate is $63.2b . This is 1.41% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $63.6b 1.97% , the lowest is $62.9b 0.92% .
This results in the following potential growth metrics:
2023 | $61.9b | 2.20% |
---|---|---|
2024 | $63.2b | 2.24% |
2025 | $66.4b | 4.99% |
2026 | $69.0b | 3.95% |
2027 | $74.3b | 7.60% |
2028 | $78.6b | 5.79% |
10 Analysts have issued an IBM EBITDA forecast 2024. The average IBM EBITDA estimate is $15.5b . This is 0.68% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $17.1b 10.85% , the lowest is $13.7b 11.12% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $14.9b | 18.54% |
---|---|---|
2024 | $15.5b | 4.35% |
2025 | $16.2b | 4.50% |
2026 | $17.0b | 4.87% |
2027 | $16.1b | 5.40% |
2028 | $16.9b | 4.67% |
2023 | 24.09% | 15.99% |
---|---|---|
2024 | 24.58% | 2.06% |
2025 | 24.47% | 0.45% |
2026 | 24.69% | 0.90% |
2027 | 21.70% | 12.11% |
2028 | 21.47% | 1.06% |
6 IBM Analysts have issued a net profit forecast 2024. The average IBM net profit estimate is $8.4b . This is 0.39% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $8.7b 4.19% , the lowest is $8.1b 3.64% .
This results in the following potential growth metrics and future Net Margins:
2023 | $7.5b | 352.22% |
---|---|---|
2024 | $8.4b | 11.86% |
2025 | $8.7b | 3.24% |
2026 | $9.3b | 7.04% |
2027 | $9.9b | 6.44% |
2028 | $10.7b | 8.59% |
2023 | 12.12% | 342.50% |
---|---|---|
2024 | 13.26% | 9.40% |
2025 | 13.04% | 1.66% |
2026 | 13.43% | 2.99% |
2027 | 13.28% | 1.12% |
2028 | 13.63% | 2.64% |
6 Analysts have issued a IBM forecast for earnings per share. The average IBM <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $9.11 . This is 0.44% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $9.45 4.19% , the lowest is $8.74 3.64% .
This results in the following potential growth metrics and future valuations:
2023 | $8.14 | 352.22% |
---|---|---|
2024 | $9.11 | 11.92% |
2025 | $9.40 | 3.18% |
2026 | $10.06 | 7.02% |
2027 | $10.71 | 6.46% |
2028 | $11.63 | 8.59% |
Current | 25.67 | 60.02% |
---|---|---|
2024 | 25.58 | 0.35% |
2025 | 24.77 | 3.17% |
2026 | 23.14 | 6.58% |
2027 | 21.74 | 6.05% |
2028 | 20.02 | 7.91% |
Based on analysts' sales estimates for 2024, the IBM stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.09 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 3.39 .
This results in the following potential growth metrics and future valuations:
Current | 4.14 | 47.33% |
---|---|---|
2024 | 4.09 | 1.28% |
2025 | 3.89 | 4.75% |
2026 | 3.74 | 3.80% |
2027 | 3.48 | 7.07% |
2028 | 3.29 | 5.47% |
Current | 3.44 | 65.04% |
---|---|---|
2024 | 3.39 | 1.39% |
2025 | 3.23 | 4.75% |
2026 | 3.11 | 3.80% |
2027 | 2.89 | 7.07% |
2028 | 2.73 | 5.47% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.